|
I'm at Liverpool University http://www.ismef.it/stmap_3f470.html?viagra.lotrel.malegra-dxt safe2choose.org reviews "I think this will help clinicians make more rational decisions about whom to treat with testosterone," said Finkelstein. "It also teaches clinicians that there is no one answer to what's a low level. If the patient's interested in sexual function, it's one level. If they're interested in bone loss, it's another level. Unfortunately it's not one size fits all."
|